Commentary: Liquid Biopsy for Average-Risk Colorectal Cancer Screening

David A. Lieberman; Aasma Shaukat; Folasade P. May; John M. Carethers; Iris Lansdorp-Vogelaar; Uri Ladabaum; Timothy R. Church; Anjelica Davis; Chyke A. Doubeni; John M. Inadomi; Richard C. Wender; Pedro Nascimento de Lima; Rosita van den Puttelaar

Abstract

The American Gastroenterological Association convened a workshop to summarize the evidence on emerging blood tests for CRC screening. This paper reports those findings and provides consensus statements from the workshop's expert panel.

Publication Impact Statistics

Topics

liquid biopsy colorectal cancer cancer screening average risk biomarkers circulating tumor DNA early detection preventive medicine gastroenterology clinical guidelines screening guidelines non-invasive testing

Citation

@article{LIEBERMAN2024,
title = {Commentary: Liquid Biopsy for Average-Risk Colorectal Cancer Screening},
journal = {Clinical Gastroenterology and Hepatology},
year = {2024},
issn = {1542-3565},
doi = {10.1016/j.cgh.2024.01.034},
month = may,
url = {https://www.sciencedirect.com/science/article/pii/S1542356524001629},
author = {David A. Lieberman and Aasma Shaukat and Folasade P. May and John M. Carethers and Iris Lansdorp-Vogelaar and Uri Ladabaum and Timothy R. Church and Anjelica Davis and Chyke A. Doubeni and John M. Inadomi and Richard C. Wender and Pedro {Nascimento de Lima} and Rosita {van den Puttelaar}}
}